Clermont, FL, United States of America

Yunik Chang

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Dow Pharmaceutical Sciences, Inc., Medigene Ag, Fougera Pharmaceuticals Inc.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunik Chang. Retrieved from https://idiyas.com/inventor/yunik-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 95.2


 

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 258(Granted Patents)


Location History:

  • Sonoma, CA (US) (2002 - 2017)
  • Clermont, FL (US) (2016 - 2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Benzoyl Peroxide
Topical Formulations
Viral Skin Treatment
Tumor Diseases
Kinetin
Zeatin
Metronidazole
Sustained Release
Aqueous Compositions
Gel Compositions
Alpha Hydroxy Acid
21 patents (USPTO):Explore Patents

Title: **Innovative Solutions in Dermatology: The Contributions of Yunik Chang**

Introduction

Yunik Chang, based in Clermont, Florida, is a distinguished inventor known for his significant contributions to the field of pharmaceutical formulations. With an impressive portfolio of 21 patents, Chang has dedicated his career to innovating solutions for skin-related issues, particularly acne.

Latest Patents

Among his latest advancements, Chang developed a revolutionary topical pharmaceutical formulation that incorporates a low concentration of benzoyl peroxide suspended in an aqueous medium enhanced by a water-miscible organic solvent. This formulation aims to deliver benzoyl peroxide in a stable and effective manner without the need for surfactants. The unique ratio of water and organic solvent ensures that the benzoyl peroxide remains in saturated solubility, thereby enhancing its efficacy in treating acne and acne rosacea. Notably, the concentration of benzoyl peroxide is maintained between 1.0% to less than 5.0% w/w, making it both potent and gentle for skin application.

Career Highlights

Chang's career includes stints at notable companies such as Dow Pharmaceutical Sciences, Inc. and Medigene AG, where he honed his expertise in the development of dermatological treatments. His work at these institutions not only refined his skills but also provided him with the tools to innovatively tackle common skin concerns. His collective experiences have led to the formulation of significant patents that empower individuals in their battle against acne and other skin conditions.

Collaborations

Throughout his career, Chang has collaborated with esteemed professionals including Gordon J. Dow and Radhakrishnan Pillai. These partnerships have fostered an environment of innovation, further driving advancements in pharmaceutical formulations and enhancing the efficacy of dermatological products.

Conclusion

Yunik Chang's relentless pursuit of innovation in the field of pharmaceutical formulations displays his commitment to improving the lives of those suffering from acne and related skin issues. With 21 patents to his name and collaboration with industry experts, Chang continues to make remarkable strides in dermatology, paving the way for effective treatment options. His contributions not only reflect his ingenuity as an inventor but also signify a brighter future for acne sufferers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…